Home
Alembic Pharmaceuticals Limited
Press Release Nov 14 2022
Business
Nov 14 2022
3 min read

Press Release Nov 14 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 14-Nov-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Cyclophosphamide Capsules, 25 mg and 50 mg.

View Attachment